Yes Canada’s recreational market will provide a significant market where demand is expected to outstrip supply in the near to mid-term, but Canadian cannabis companies are looking beyond. And planning accordingly. There are several publicly traded companies within Canada that have already expanded to, or initiated plans to enter the European market.
Aphria Inc. (TSX:APH; OTC:APHQF; FRA:10E) recently announced the acquisition of Nuuvera Inc. (TSXV:NUU), who has a strong presence in Europe, Africa and the Middle East and will leverage Nuuvera’s international network and best-in-class manufacturing practices to become a preeminent global supplier of premium cannabis. Nuuvera’s has key relationships in countries such as Italy (owns one of only seven licenses to import), Spain, the UK, and Germany (not to mention Israel and Uruguay, who themselves have become global cannabis players in some form as well). Clearly geared towards global expansion, this acquisition provides Aphria with a strong footprint in Europe going forward. Vic Neufeld, CEO of Aphria, reiterates the importance of this acquisition, stating that coupled with Aphria’s ability to grow high quality cannabis at a low cost, that Nuuvera’s “expansive international network, expertise in processing, and access to industry leading technology” is poised to play a significant role in their success going forward. Aphria also made the news in Greece recently, as Greek Parliament approved the cultivation and production of medical cannabis for domestic or exports. With reported plans to develop a 92,000 square meter greenhouse with capacity for over 100 tons in the northeastern region of Xanthi this year, Aphria is poised to be one of the biggest producers right off the bat.
Already the leading exporter to and distributor of medical cannabis in Germany through its wholly-owned subsidiary Pedanios, Aurora Cannabis Inc. (TSX:ACB; OTC:ACBFF; FRA:21P; WKN:A1C4WM) an-nounced in January that it was partnering with a somewhat out of the box partner, Danish tomato and pepper producer Alfred Pedersen &
Son, to produce and sell cannabis in Europe. That news may have gotten lost in the meltdown
of the cannabis
sector caused by the rescinding of the Cole Memo by U.S. Attorney
134
134
Yes Canada’s recreational market will provide a significant market where demand is expected to outstrip supply in the near to mid-term, but Canadian cannabis companies are looking beyond. And planning accordingly. There are several publicly traded companies within Canada that have already expanded to, or initiated plans to enter the European market.
Aphria Inc. (TSX:APH; OTC:APHQF; FRA:10E) recently announced the acquisition of Nuuvera Inc. (TSXV:NUU), who has a strong presence in Europe, Africa and the Middle East and will leverage Nuuvera’s international network and best-in-class manufacturing practices to become a preeminent global supplier of premium cannabis. Nuuvera’s has key relationships in countries such as Italy (owns one of only seven licenses to import), Spain, the UK, and Germany (not to mention Israel and Uruguay, who themselves have become global cannabis players in some form as well). Clearly geared towards global expansion, this acquisition provides Aphria with a strong footprint in Europe going forward. Vic Neufeld, CEO of Aphria, reiterates the importance of this acquisition, stating that coupled with Aphria’s ability to grow high
quality cannabis at a low cost, that Nuuvera’s “expansive international network, expertise in processing, and access to industry leading technology” is poised to play a significant role in their success going forward. Aphria also made the news in Greece recently, as Greek Parliament approved the cultivation and production of medical cannabis for domestic or exports. With reported plans to develop a 92,000 square meter greenhouse with capacity for over 100 tons in the northeastern region of Xanthi this year, Aphria is poised to be one of the biggest producers right off the bat.
Already the leading exporter to and distributor of medical cannabis in Germany through its wholly-owned subsidiary Pedanios, Aurora Cannabis Inc. (TSX:ACB; OTC:ACBFF; FRA:21P; WKN:A1C4WM) an-nounced in January that it was partnering with a somewhat out of the box partner, Danish tomato and pepper producer Alfred Pedersen &
Son, to produce and sell cannabis in Europe. That news may have gotten lost in the meltdown
of the cannabis
sector caused by the rescinding of the Cole Memo by U.S. Attorney